Tony Tsz-Cheong Ng

Title: Tony Tsz-Cheong Ng: Innovator in Tumor Metastasis Prediction

Introduction

Tony Tsz-Cheong Ng is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in understanding tumor metastasis. His innovative work has led to the development of methods that can predict the risk of metastatic recurrence in tumors.

Latest Patents

Tony Tsz-Cheong Ng holds a patent titled "Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence." This patent outlines methods and products for determining if a subject with a tumor is at risk of metastasis. The methods involve detecting phosphorylated cofilin and quantifying both phosphorylated and non-phosphorylated cofilin. By analyzing the ratio of phosphorylated cofilin to the total amount of cofilin detected, the methods can predict the likelihood of tumor metastasis. This innovative approach has the potential to significantly impact cancer treatment and patient outcomes.

Career Highlights

Throughout his career, Tony has worked with prestigious institutions such as Albert Einstein College of Medicine and King's College London. His research has focused on the mechanisms of tumor progression and the development of predictive tools for cancer treatment.

Collaborations

Tony has collaborated with esteemed colleagues, including John S Condeelis and Gregory Weitsman. These partnerships have enhanced his research and contributed to advancements in the understanding of tumor biology.

Conclusion

Tony Tsz-Cheong Ng is a pioneering inventor whose work in tumor metastasis prediction is making a significant impact in the field of cancer research. His innovative methods and collaborations continue to advance our understanding of cancer and improve patient care.